4//SEC Filing
Reisman Neil 4
Accession 0000899243-19-010289
CIK 0001576263other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 9:20 PM ET
Size
5.7 KB
Accession
0000899243-19-010289
Insider Transaction Report
Form 4
Reisman Neil
10% Owner
Transactions
- Other
Common Stock
2019-04-04−54,210→ 87,607 total
Footnotes (2)
- [F1]Reflects 54,210 shares received by Neil Reisman in connection with the transfer by MVA Investors, LLC ("MVA Investors") on April 4, 2019 of 180,926 shares of the common stock of the issuer, on a pro rata basis for no consideration.
- [F2]These securities are owned directly by the reporting person, which has sole voting and dispositive power with respect to these securities. The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. ("Braslyn"), (ii) Boxer Capital, LLC ("Boxer Capital"), (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) MVA Investors, (v) Tuesday Thirteen Inc., (vi) Joe Lewis, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) the reporting person, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the "Boxer Group). Each member of the Boxer Group other than the reporting person disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001465834
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 9:20 PM ET
- Size
- 5.7 KB